All samples sent to the molecular department of the clinical laboratory of the Jessa Hospital (Hasselt, Belgium) for determination of SARS-CoV-2 between August 1, 2020 and November 20, 2020 were included. The inclusion criterion for the follow-up study was the presence of a borderline SARS-CoV-2 test result accompanied by a follow-up test within 96 hours.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.